Legislative Observatory
European Parliament
Please fill in this field to find a procedure

2010 discharge: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

2011/2216(DEC)

PURPOSE: presentation of the EU Court of Auditors’ report on the annual accounts of the European Monitoring Centre for Drugs and Drug Addiction together with the Centre’s reply.

CONTENT: in accordance with the tasks conferred on the Court of Auditors by the Treaty on the Functioning of the European Union, the Court presents to the European Parliament and to the Council, in the context of the discharge procedure, a Statement of Assurance as to the reliability of the annual accounts of each institution, body or agency of the EU, and the legality and regularity of the transactions underlying them, on the basis of an independent external audit.

This audit concerned, amongst others, the annual accounts of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

In the Court’s opinion, the Centre’s Annual Accounts fairly present, in all material respects, its financial position as of 31 December 2010 and the results of its operations and its cash flows for the year then ended, in accordance with the provisions of its Financial Regulation.

The Court also considers that the transactions underlying the annual accounts of the Centre for the financial year ended 31 December 2010 are, in all material respects, legal and regular.

The report confirms that the Centre’s 2010 budget amounted to EUR 16 million and that the   number of staff employed by the Centre at the end of the year was 78.

The report also makes a series of observations on the budgetary and financial management of the Centre, accompanied by the latter’s response.

It should be noted that the report makes no observations on the budgetary and financial management of the Foundation.

Lastly, the Court of Auditors’ report contains a summary of the Centre’s activities in 2010. This is focused on the following:

  • running a computerised network for the collection and exchange of information called the ‘European Information Network on Drugs and Drug Addiction’ (Reitox);
  • various publications (e.g. annual report on the state of the drug problem in Europe; publication on selected issues; statistical bulletin and interactive website);
  • setting-up/updating/content development of public EMCDDA website;
  • publication of promotional brochures, media products, press releases and fact sheets;
  • taking part in international conferences and meetings;
  • organising scientific and technical meetings.